These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 10482217)

  • 1. Myeloid colony-stimulating factors: use in the newborn.
    Sreenan C; Osiovich H
    Arch Pediatr Adolesc Med; 1999 Sep; 153(9):984-8. PubMed ID: 10482217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. G-CSF and GM-CSF for treating or preventing neonatal infections.
    Carr R; Modi N; Doré C
    Cochrane Database Syst Rev; 2003; 2003(3):CD003066. PubMed ID: 12917944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of G-CSF GM-CSF in the management of infections in preterm newborns: an update.
    Castagnola E; Dufour C
    Early Hum Dev; 2014 Sep; 90 Suppl 2():S15-7. PubMed ID: 25220119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor have differential effects on neonatal and adult neutrophil survival and function.
    Molloy EJ; O'Neill AJ; Grantham JJ; Sheridan-Pereira M; Fitzpatrick JM; Webb DW; Watson RW
    Pediatr Res; 2005 Jun; 57(6):806-12. PubMed ID: 15718363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hematopoietic growth factors in prevention and therapy of infectious complications in premature and newborn infants].
    Lehrnbecher T
    Z Geburtshilfe Neonatol; 2001; 205(5):167-73. PubMed ID: 11727663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential use of granulocyte colon-stimulating factor and granulocyte-macrophage colony-stimulating factor in neonates.
    Bracho F; Goldman S; Cairo MS
    Curr Opin Hematol; 1998 May; 5(3):215-20. PubMed ID: 9664163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized trial of granulocyte-macrophage colony-stimulating factor in neonates with sepsis and neutropenia.
    Bilgin K; Yaramiş A; Haspolat K; Taş MA; Günbey S; Derman O
    Pediatrics; 2001 Jan; 107(1):36-41. PubMed ID: 11134431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hematopoietic growth factors in prophylaxis and therapy of infections complications in children with neutropenia].
    Lehrnbecher T
    Klin Padiatr; 2001; 213(4):212-38. PubMed ID: 11528556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of myeloid colony-stimulating factors in neonates with septicemia.
    Bernstein HM; Calhoun DA; Christensen RD
    Curr Opin Pediatr; 2002 Feb; 14(1):91-4. PubMed ID: 11880741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rationale and potential use of cytokines in the prevention and treatment of neonatal sepsis.
    Goldman S; Ellis R; Dhar V; Cairo MS
    Clin Perinatol; 1998 Sep; 25(3):699-710. PubMed ID: 9779342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, controlled trial of prophylactic granulocyte-macrophage colony-stimulating factor in human newborns less than 32 weeks gestation.
    Carr R; Modi N; Doré CJ; El-Rifai R; Lindo D
    Pediatrics; 1999 Apr; 103(4 Pt 1):796-802. PubMed ID: 10103305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contrasting effects of recombinant human granulocyte-macrophage colony-stimulating factor (CSF) and granulocyte CSF treatment on the cycling of blood elements in childhood-onset cyclic neutropenia.
    Wright DG; Kenney RF; Oette DH; LaRussa VF; Boxer LA; Malech HL
    Blood; 1994 Aug; 84(4):1257-67. PubMed ID: 7519479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of colony-stimulating factors and granulocyte transfusion in treatment options for neutropenia in children with cancer.
    Liang DC
    Paediatr Drugs; 2003; 5(10):673-84. PubMed ID: 14510625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neonatal neutropenia: what diagnostic evaluation is needed and when is treatment recommended?
    Del Vecchio A; Christensen RD
    Early Hum Dev; 2012 May; 88 Suppl 2():S19-24. PubMed ID: 22633505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Granulocyte-macrophage colony stimulating factor administered as prophylaxis for reduction of sepsis in extremely preterm, small for gestational age neonates (the PROGRAMS trial): a single-blind, multicentre, randomised controlled trial.
    Carr R; Brocklehurst P; Doré CJ; Modi N
    Lancet; 2009 Jan; 373(9659):226-33. PubMed ID: 19150703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Granulocyte macrophage-colony stimulating factor (GM-CSF) in neonatal neutropenia.
    Ray M; Mukhopadhyay K; Narang A
    Indian J Pediatr; 2000 Jan; 67(1):67-8. PubMed ID: 10832225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of recombinant granulocyte colony-stimulating factor, recombinant human granulocyte-macrophage colony-stimulating factor and placebo for treatment of septic preterm infants.
    Ahmad A; Laborada G; Bussel J; Nesin M
    Pediatr Infect Dis J; 2002 Nov; 21(11):1061-5. PubMed ID: 12442030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in the treatment of patients with HIV infection.
    Frumkin LR
    Curr Opin Hematol; 1997 May; 4(3):200-6. PubMed ID: 9209837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor: comparisons and potential for use in the treatment of infections in nonneutropenic patients.
    Root RK; Dale DC
    J Infect Dis; 1999 Mar; 179 Suppl 2():S342-52. PubMed ID: 10081506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of granulocyte and granulocyte macrophage colony stimulating factors (G-CSF and GM-CSF) on neonatal neutrophil functions.
    Wolach B; Gavrieli R; Pomeranz A
    Pediatr Res; 2000 Sep; 48(3):369-73. PubMed ID: 10960505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.